About Link-Company

This author has not yet filled in any details.
So far Link-Company has created 3 blog entries.

About VORONOI

2020-01-15T11:07:00+00:00

[:ko]보로노이 그룹은 모회사인 보로노이, 자회사인 보로노이바이오와
비투에스바이오로 이루어져있습니다. 보로노이는 연구/개발 전단계에 함께하면서
임상개발을 주도하고 보로노이바이오는 분자모델링과 Kinase inhibitor,
비투에스바이오는 TPD를 전문적으로 연구/개발하고 있습니다.[:en]Voronoi Group consists of the parent company Voronoi and its subsidiaries Voronoi Bio and B2S Bio. Voronoi leads clinical development throughout the R&D journey. Voronoi Bio focuses on R&D of molecular modeling and kinase inhibitor, and B2S Bio focuses on TPD.[:]

About VORONOI2020-01-15T11:07:00+00:00

Our work

2020-01-28T16:10:14+00:00

[:ko]희귀 난치성 질환의 치료를 목표로 TPD(Target protein degraders), Kinase inhibitor
신약을 개발하고 있습니다. 질병에 대한 높은 이해와 혁신적인 기술을 바탕으로
경쟁력 있는 치료제를 개발하고 있습니다.[:en]Voronoi develops novel TPD (Target protein degraders) and kinase inhibitors with the aim to treat intractable and rare diseases. We are developing competitive therapies based on deep understanding of diseases and innovative technologies. [:]

Our work2020-01-28T16:10:14+00:00